Marta Coscia

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin et al. · Leukemia · 2020 · 271 citations · Full text

Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

Marta Coscia, Elena Quaglino, Manuela Iezzi et al. · Journal of Cellular and Molecular Medicine · 2009 · 263 citations · Full text

Chemoprevention Strategy, Immunology, Cancer Biology +21

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Roberto Piva, Bruce Ruggeri, Michael Williams et al. · Blood · 2007 · 252 citations · Full text

The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia

Davide Brusa, Sara Serra, Marta Coscia et al. · Haematologica · 2013 · 219 citations · Full text

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

Davide Rossi, Lodovico Terzi-di-Bergamo, Lorenzo De Paoli et al. · Blood · 2015 · 212 citations · Full text